Which closed-end funds own Alnylam Pharmaceuticals Inc?
5 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $10.9M. Security type: common equity. Country: United States. CUSIP 02043Q107 · ISIN US02043Q1076 · ticker ALNY.
Holdings are historical filings (report dates Jun 30, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| HQL abrdn Life Sciences Investors | Healthcare | 0.72% | $5M | 16,515 sh | $690M | 3.5% discount | Jun 30, 2026 |
| ASG Liberty All Star Growth Fund | U.S. Equity | 0.51% | $2M | 6,725 sh | $398M | 13.4% discount | Jun 30, 2026 |
| BME BlackRock Health Sciences Trust | Healthcare | 0.44% | $2.5M | 8,378 sh | $573M | 3.7% discount | Jun 30, 2026 |
| SPXX Nuveen S&P 500 Dynamic Overwrite Fund | Covered Call / Option Income | 0.05% | $1.3M | 4,477 sh | $2.9B | NAV unavailable | Jun 30, 2026 |
| BRW Saba Capital Income & Opportunities Fund | U.S. Equity | -0.00% | $-5.1K | -25 sh | $351M | 17.8% discount | Jul 31, 2026 |
5 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Alnylam Pharmaceuticals Inc | debt security | 3 |
| Alnylam Pharmaceuticals, Inc. | debt security | 2 |
Issuer-level search for “ALNY” → · Compare two funds’ portfolios →